William Blair & Company’s GoHealth GOCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,981
Closed -$11K 1842
2022
Q3
$11K Buy
1,981
+948
+92% +$7.14K ﹤0.01% 1733
2022
Q2
$9K Sell
1,033
-13
-1% -$151 ﹤0.01% 1777
2022
Q1
$19K Sell
1,046
-245
-19% -$7.63K ﹤0.01% 1797
2021
Q4
$73K Buy
1,291
+78
+6% +$5.21K ﹤0.01% 1727
2021
Q3
$91K Buy
1,213
+312
+35% +$33K ﹤0.01% 1622
2021
Q2
$151K Sell
901
-869
-49% -$152K ﹤0.01% 1559
2021
Q1
$310K Sell
1,770
-1,315
-43% -$265K ﹤0.01% 1318
2020
Q4
$632K Buy
3,085
+1,581
+105% +$294K ﹤0.01% 1015
2020
Q3
$294K Buy
+1,504
New +$362K ﹤0.01% 1154

Other funds holding GOCO

William Blair & Company's GOCO Position: Q4 2022 in Review

William Blair & Company sold out of GoHealth (GOCO) in Q4 2022, closing a stake of 1,981 shares — an estimated $11K sold.

William Blair & Company first reported a position in GOCO in Q3 2020 and held it in 9 quarters. The position peaked at $632K in Q4 2020. 35 funds tracked by Wall St. Rank hold GOCO as of Q4 2022.

  • William Blair & Company reported no remaining GoHealth position as of Q4 2022 after selling out during the quarter.
  • William Blair & Company sold 1,981 GoHealth shares in Q4 2022, an estimated $11K.
  • William Blair & Company first reported a position in GoHealth in Q3 2020 and held it in 9 quarters.
  • William Blair & Company's GoHealth position peaked at $632K in Q4 2020.
  • 35 funds tracked by Wall St. Rank held GoHealth as of Q4 2022.

Based on William Blair & Company's 13F filing for Q4 2022, filed 10 Feb 2023.